PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, 3000, Leuven, Belgium.\', \'Global Virus Network, GVN, Baltimore, MD, USA.\', \'KU Leuven, Department of Pharmaceutical and Pharmacological Sciences, Drug Delivery & Disposition, Box 921, 3000, Leuven, Belgium.\', \'KU Leuven Department of Imaging and Pathology, Translational Cell and Tissue Research, 3000, Leuven, Belgium.\', \'Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.\', \'Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.\', \'Drugs for Neglected Diseases initiative, Geneva, Switzerland.\', \'KU Leuven Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, 3000, Leuven, Belgium. johan.neyts@kuleuven.be.\', \'Global Virus Network, GVN, Baltimore, MD, USA. johan.neyts@kuleuven.be.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41467-022-28354-0
?:doi
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 35169114
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all